Abstract-A specialized in vivo exposimetry system was developed to acquire transahdominal in situ ultrasound exposure quantities in obstetric patients. Under surgical conditions, the sterilized 7-element calibrated linear array hydrophone was introduced into the uterus under direct ultrasound guidance and placed in direct contact with the products of conception, usually in the saggital midplane of the uterine cavity. Twentyfive patients with empty bladders and 10 patients with full bladders were studied at gestational ages between 7 and 20 weeks. In the empty bladder condition, the sound beam traversed the anterior abdominal wall, uterus, amniotic fluid and fetal parts and in the full bladder condition, the sound beam also traversed the fluid-filled bladder. Each study was conducted with a 3 MHz, mechanical sector transducer in combination with an ATL Ultramark 4 diagnostic ultrasound imaging system. Calibration data were recorded after completion of each in vivo patient study. The acquired exposimetry data from the 35 obstetric patients were used to evaluate the appropriateness of three tissue attenuation models, viz., j?xed path, homogeneous and overlying. All three tissue models yield a mean attenuation coefficient value of about a factor of 3 to 4 greater than their respective minimum values. In the case of the overZying and homogeneous tissue models, there was a statistically significant correlation between their calculated attenuation coefficients and total distance for the combined data set whereas there was no such dependency for the ealeulated Jixedputh tissue model. In summary, any one of the three tissue models may be used to estimate in utero acoustic quantities during the first and second trimesters of human pregnancy based on this study.
INTRODUCTION
Ultrasonic dosimetry (O'Brien 1992) is concerned with the quantitative determination of ultrasonic energy interaction with biological materials, that is, defining the quantitative relationship between an ultrasound exposure level and the biological effect it produces. Embryo and fetal ultrasound bioeffects have been extensively reviewed over the past few years (AIUM 1988 (AIUM , 1993 Miller and &kin 1989; NCRP 1983 NCRP , 1992 NIH 1984; Taran-tal and O'Brien 1994; O'Brien 1991; WFUMB 1989 WFUMB , 1992 Ziskin and Pittiti 1988) . Overall, some conclusions can be drawn from these reports. If ultrasound as a physical agent were capable of inducing gross malformations, then a rise in the occurrence of birth defects would have been documented by now, although a very small rise may not be detectable without extremely large sample sizes. This has not been the case, as epidemiological studies have shown no significant correlations between a rise in its use and the incidence of congenital anomalies. However, based on the fact that results of experimental studies have proven inconsistent, it is clear that the interaction of ultrasound with biological systems, particularly those with rapidly dividing cells, is still not fully understood. What remains of concern are the subtle and/or long-term manifestations of frequent intrauterine exposure. These concerns remain pertinent due to a number of factors such as the continued rise in the percentage of the prenatal population that is ex-posed each year. In addition, as advances in technology are made, the exposure parameters for the fetus can also change. The use of pulsed Doppler (and color how imaging) are good examples; these methods have been applied more recently for evaluating physiologic function and rely on time-average output parameters that are greater than those for routine imaging. The exposure time may also be increased as additional diagnostic information is sought. These points emphasize the need to pursue these questions in an effort to confirm that unwanted effects do not occur.
The recently approved Output Display Standard (AIUM/NEMA 1992) addresses one aspect of ultrasound dosimetry in which the user of diagnostic ultrasound equipment is provided with quantitative indices which relate to temperature increase, the thermal index, and the potential for cavitation, the mechanical index, from the diagnostic ultrasound field. In its development, certain aspects of the tissue in which the ultrasound wave propagated had to be assumed in order to estimate in situ ultrasound exposure levels. Ultrasound exposimetry, a necessary component of ultrasound dosimetry, is thus concerned with the quantitative determination of ultrasonic exposure levels in biological materials and the development of quantitative tissue models is a necessary part of such studies.
There is, therefore, a need for realistic tissue models to predict in situ acoustic exposure levels from measurements of acoustic output made in water in order to have an improved basis for estimating risk. Both national (AIUM 1988 (AIUM , 1993 AIUM/NEMA 1992; NCRP 1983 NCRP , 1992 and international (WFUMB 1989 (WFUMB , 1992 organizations, as well as research groups (Akaiwa 1989; Carson et al. 1989; Carson 1989; Ranmarine et al. 1993; Siddiqi et al. 1991 Siddiqi et al. , 1992 Smith et al. 1985) , have been evaluating and/or developing models and guidelines. For example, the US Food and Drug Administration (FDA 1985 (FDA , 1993 uses a homogeneous tissue model, also referred to as a derating model, in their 510(k) process which is required by manufacturers and importers of diagnostic ultrasound devices in the United States to estimate in situ exposure levels. The homogeneous tissue model assumes that the propagated ultrasound wave travels through a uniform tissue medium with a derating factor of 0.3 dB/ cm-MHz. It could be argued that this derating factor is conservative, that is, its application will generally yield an in situ acoustic exposure level greater than the actual in situ level because the tissue attenuation is greater than 0.3 dB/cm-MHz.
However, for fetal imaging applications where the propagated ultrasound wave traverses through the fluid-filled bladder fluid, it could be argued that this derating factor is reasonable when the tissue path consists of 60% soft tissue (attenuation assumed to be 0.5 dB/cm-MHz ) and 40% fluid (attenuation assumed to be negligible ). If the total traversed path consists of more than 40% fluid, then it could be argued that this derating factor underestimated the in situ acoustic exposure levels.
In human pregnancy, the embryonic stage of development includes the first eight weeks after fertilization. This is the period of cell division and organogenesis which is complete once the human embryo enters the fetal stage. Any damage to dividing cells or organelles at this stage may translate into major abnormalities at birth. Experimental data provide almost no information with respect to the threshold levels of ultrasound for the induction of lethal and nonlethal abnormalities and where existing, such data are conflicting. As an essential first step, it is critical to determine the actual ultrasonic levels to which the human embryo is exposed. We have constructed a specialized in vivo exposimetry system, developed and tested customized software and determined selected first-order and second-order ultrasonic field quantities during a routine reproductive ultrasound examination of the human ovary (Daft et al. 1990; Siddiqi et al. 1991 ) .
Using the previously described customized equipment, the current study was designed to determine selected first-order and second-order ultrasonic field quantities to which the human embryo and fetus are exposed during the course of a "routine" diagnostic ultrasound examination. As a first step towards determining risk, we used these experimentally obtained exposure data to estimate the appropriate derating factor for each of three proposed clinical tissue models for ultrasound dosimetry calculations in the obstetric patient: ( 1 ) Fined path ( fp), (2) Homogeneous (ho ), (3 ) Overlying (ov ) .
METHODS
Diagnostic imaging system A 3.0 MHz frequency, mechanical sector transducer (depth of focus 5.5-13 cm, focal length 8 cm, crystal diameter 19 mm) in combination with an ATL Ultramark 4 Model (Advanced Technology Laboratories, Bothel, WA, USA) diagnostic ultrasound imaging system was used for all studies. Exposure time after obtaining an acceptable real-time image was 5 min. Power setting for the system was 100% at all times.
Exposimetry instrumentation
The customized exposimetry equipment and software for in vivo and calibration (in vitro) measurements have been previously reported in detail (Siddiqi et al. 1991) . In summary, instrumentation has been In siru human obstetrical ultrasound exposimetq 0 T. A. SIDDIQI et al. 3x1 developed to measure acoustic pressure (AIUM/ NEMA 1992) during a diagnostic reproductive system ultrasound examination. The acoustic pressure field is sampled using a calibrated 7-element linear array hydrophone of polyvinylidine difluoride transducers, which is introduced into the uterus through the dilated cervix in a sterile fashion, and placed in contact with the nonviable human embryo using real-time imaging. The radio-frequency (RF) signals from the hydrophone are digitized at 50 megasamples per second and the received temporal waveform which has the maximum amplitude in the examination is recorded. The reference output of the clinical real-time scanner is obtained by placing the hydrophone in a temperature controlled (37°C) water bath at the same range from the clinical transducer as that used to obtain the in vivo temporal waveform recording. From the digitized hydrophone recordings, 10 exposimetry quantities are estimated, 5 under in vivo conditions and 5 in the water tank, that is, in vitro conditions. The 5 quantities for each condition are the peak compressional pressure, pC, the peak rarefactional pressure, pr, the temporal peak intensity, ZTP, the pulse average intensity, IPA, and the temporal average intensity, ZrA (AIUM 1992; Daft et al. 1990; Siddiqi et al. 1991 Siddiqi et al. , 1992 .
Patient population
Otherwise healthy first-and second-trimester pregnant subjects with a sonographically confirmed diagnosis of missed abortion were recruited to the study after the clinical decision to perform a dilatation and curettage had been made by their primary physician. Each subject was counseled and asked to sign an informed consent statement as approved by the University of Cincinnati Medical Center Institutional Review Board. Each subject was studied only once for data analysis.
The patients were divided into two groups: Group EB (25 subjects: 15 first trimester and 10 second trimester) was comprised of subjects whose bladder was empty and the ultrasound beam traversed the anterior abdominal wall, uterine wall and amniotic fluid prior to visualization of the hydrophone which was in contact with the products of conception in the uterine cavity (Fig. 1) ; Group FB ( 10 subjects: 9 first trimester and 1 second trimester) was comprised of subjects who had a full bladder and the ultrasound beam traversed the anterior abdominal wall, distended bladder, uterine wall and amniotic fluid prior to visualization of the hydrophone which was in contact with the products of conception in the uterine cavity (Fig. 2) . Overall patient size and the presence or absence of a distended urinary bladder therefore affected the total distance between the abdominal wall skin surface (transducer) and the products of conception (hydrophone ) .
Hydrophone placement and study protocol For first-trimester patients, each patient was prepped and draped in the usual fashion for a firsttrimester dilatation and curettage. After appropriate anesthesia had been administered by either the responsible anesthesiologist or primary care physician, a selfretaining vaginal speculum was inserted and the cervix was visualized and cleansed together with the vagina with an antiseptic solution (betadine). The cervix was then dilated with graduated dilators in a standard fashion. At this time, one of the authors (TAS) who was also scrubbed for surgery introduced the sterilized exposimetry hydrophone into the uterus under direct ultrasound guidance. The hydrophone was placed in direct contact with the products of conception, usually in the saggital midplane of the uterine cavity. The lower end of the hydrophone has a recognizable round flange to help ensure appropriate placement and orientation of the linear array of transducers. The thicknesses of each of the previously listed tissue layers between the transducer and the hydrophone were then measured separately as well as the total distance between the transducer and the hydrophone.
In a similar fashion, second-trimester patients undergoing prostaglandin induction of abortion, were studied by inserting the exposimetry hydrophone into the uterine cavity using sterile technique prior to administration of prostaglandin E2 20 mg suppositories.
In vivo data were then obtained at 100% power setting of the diagnostic imaging system. In summary, the transducer was moved across the abdominal wall surface with real-time imaging ensuring constant hydrophone visualization. The largest hydrophone signal was saved for analysis. Reference (in vitro) data were recorded immediately after completion of each of the in vivo studies from a tank filled with water at body temperature (37°C) and with the transducer and hydrophone fixed at the same total distance as the in vivo state. Again, the largest signal recorded during the in vitro procedure was saved for data analysis.
Data analysis
For each subject, one complete data set of in vivo and in vitro acoustic pressure waveforms was obtained with a corresponding sonogram for total distance and tissue thickness measurements. Six acoustic insertion loss (IL) values (loss as determined by the measurement procedure) were calculated for each subject, i.e., IL = -20 log,, in vivo pressure . rn vitro pressure (indB) (1.6-5.2) @& (cm) 4.4 lr 2.2 7.5 + 1.5 0.0008 5.6 -+ 2.4 (1.9-9.0) (4.9-9.9) ( 1.9-9.9) +Ld, (cm) The (IL) was determined as previously described (Daft et al. 1990; Siddiqi et al. 1991 Siddiqi et al. , 1992 . The (IL) in dB for each subject represents: acoustic pressure measurements (see eqn 3) using a customized exposimetry system (Daft et al. 1990 ). The total distance (d,,,) between the skin surface and the hydrophone is the sum of the individual thicknesses, that is, d total = 4+x, wau + &adder + &mm + km fluld + dfetal parrs (in cm) (6) where AM wa~~9 &tidery dutemsT d, fluid and Aeta, parts are the individual thicknesses for the abdominal wall, bladder (dbladder assumed zero for EB group), I.&X-US, amniotic fluid and fetal parts, respectively. The individual distance (thickness) measurements were made on-line using electronic calipers. Calculations were based on three published tissue models, viz., fixed path (Carson et al. 1989; NCRP 1992; Siddiqi et al. 1991) , homogeneous (FDA 1985 (FDA , 1993 NCRP 1992) and overlying (Daft et al. 1990; Siddiqi et al. 1991 Siddiqi et al. , 1992 . The power spectra of the in vivo and i n vitro pressure waveforms exhibited a maximum at about 2.4 MHz and therefore, for these three tissue models, 2.4 MHz was used for the center frequency, fc .
The "fixed-path" (fp) tissue model is based on the assumptions that the ultrasonic attenuation between in Medicine and Biology Volume 2 1, Number 3, I995 m Homogeneous --CFixed-path cFoJ 66717189920 7 7 8 8 9 9 9 9 9 10 10 11 11 12 12 14 15 I5 15 16 17 18 19 19 20 c3c3latioMl AgeE (weeka) Gesutionrl Age-E?3 (weeka) Fig. 3 . Summary of the attenuation coefficients for the three tissue models for both the full bladder (FB) and empty bladder (EB) conditions as a function of gestational age.
the skin surface and conceptus is linearly dependent upon frequency and independent of distance (Carson et al. 1989; NCRP 1992; Siddiqi et al. 1991) . The fzxed-path attenuation coefficient for each subject is determined by the eqn (7) where (IL) is the mean insertion loss in dB (see eqn 3) and A. is the center frequency in MHz for each subject. The "homogeneous" (ho) tissue model is based on the assumption that the ultrasonic attenuation occurs uniformly over the total distance between the skin surface and the conceptus (FDA 1985 (FDA , 1993 NCRP 1992 ) . The homogeneous attenuation coefficient for each subject is determined by the eqn Abo=~(incm~Hz).
The "overlying " (ov) tissue model is based on the assumptions that the ultrasonic attenuation occurs uniformly within intact tissue only and that there is negligible attenuation from any intervening fluid path (Daft et al. 1990; Siddiqi et al. 1991 Siddiqi et al. , 1992 . The overlying attenuation coefficient for each subject is determined by the eqn
where d,, is the thickness of the overlying intact tissue between the skin surface and conceptus and is determined by subtracting from the total distance all intervening fluid path distances, i.e.,
Statistical methods
The two-tailed, unpaired Student t test was used to compare the means of the two unpaired groups with equivalent standard deviations. The assumption of equivalent standard deviations was tested with an F test. When the standard deviations were unequal, the two-tailed, unpaired Welch t test was used to compare the means of the two unpaired groups. Linear regression analysis was used to quantify the best-fit straight line between two variables. The slope's p value indicates the slope's significance relative to a zero slope and the adjusted sample coefficient of determination (adj r2) accounts for the variation in the dependent variable. The adj r* is the sample coefficient of determination (r') adjusted for degrees of freedom (Hamburg 1979) . The -+90% confidence intervals of the mean of the dependent variable are provided when the regression equation is shown graphically. Multiple regression analysis was used to quantify the best-fit estimate between more than two variables and the p values are determined for each of the estimated coefficients to test their significant differences from zero. Statistical significance is assumed at the 0.05 level and all statistical calculations were performed using SAS Software (Cary, NC, USA).
RESULTS

First versus second trimester
The 25 patients studied in the empty bladder (EB ) group consisted of 15 first-trimester and 10 secondtrimester subjects (see Table 1 ) . The two groups were statistically significantly different only in terms of selected physical dimensions, viz., uterus distance (p = 0.0083), amniotic fluid distance (p = 0.036) and total distance (p = 0.0065) as well as overlying distance (p = 0.0008). However, there were no statistically significant differences in the calculated quantities of (IL), or the attenuation coefficients for the three tissue models (see Fig. 3 ). Figure 3 shows graphically that there are no obvious trends of the attenuation coefficients for the three tissue models as a function of GA. Therefore, the first-and second-trimester empty bladder results are combined for subsequent analyses.
Insertion loss
Group values (mean ?I standard deviations and ranges) for all of the measured (intact tissue and fluid path distances) and calculated quantities ((IL), , (Afp)g, (Aho)g and (A,,),) for the two groups, full bladder (FB) and empty bladder (EB), are shown in Table 2 . The (IL), values for the EB (n = 25) and FB (n = 10) groups were 9.3 + 5.6 dB and 7.2 + 3.7 dB, respectively, and were not statistically significantly different (p = 0.28) and therefore were combined (n = 35) to yield 8.7 + 5.2 dB.
Linear regression analysis demonstrated (II,) to be independent of GA, dabd wallr d,, and dtotal for both the FB and EB groups and the combined groups: 
The greatest adj r2 value for these regressions was 0.04 indicating that only 4% of the total variance in (IL) is explained by that relationship.
Multiple regression analysis of (IL) as a function of the five tissue thicknesses yielded where the p values for the six coefficient terms were, respectively, 0.035, 0.35, 0.13, 0.13, <0.13 and 0.41, and for the model, p = 0.3 1.
Tissue models Two-tailed unpaired t tests between EB and FB groups for (A, &, (&. jfi and (Aov)g were not considered significant (p = 0.28, p = 0.18 and p = 0.96, respectively) and therefore the two groups for each of these quantities were combined (see Table 2 ).
Fixed-path tissue model The mean values 2 standard deviations and ranges for the jixed-path tissue model attenuation coefficients (A,) for the EB, FB and combined groups are listed in Table 2 . Linear regression analysis demonstrated the fixed-path tissue model attenuation coefficients to be independent of GA, dti _ wall 3 day and dtoral for both the FB and EB groups and the combined groups:
The greatest adj r* value for these regressions was 0.04 indicating that only 4% of the total variance in A, is explained by that relationship. ( 20) where the p values for the six coefficient terms were, respectively, 0.0083, 0.35, 0.13, 0.13, 0.13 and 0.41, and for the model, p = 0.3 1.
Homogeneous tissue model. The mean values k standard deviations and ranges for the homogeneous tissue model attenuation coefficients (Aho) for the EB, FB and combined groups are listed in Table 2 . Linear regression analysis demonstrated the homogeneous tissue model attenuation coefficients to be independent of GA, dabd wall, d,, and dtotal for both the FB and EB groups and the groups combined (save for one exception): 
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The greatest adj r2 value for these regressions was 0.24 indicating that only 24% of the total variance in Aho is explained by that relationship. Overlying tissue model. The mean values 2 standard deviations and ranges for the overlying tissue model attenuation coefficients (A,,) for the EB, FB and combined groups are listed in Table 2 . Linear regression analysis demonstrated the overlying tissue model attenuation coefficients to be independent of GA and dabdwall for both the FB and EB groups and the groups combined, and dependent on d,, and d,,td for the EB and combined group: The greatest adj r2 value for these regressions was 0.28 indicating that only 28% of the total variance in A,, is explained by that relationship. 
DISCUSSION
We have previously reported that in viva ultrasound exposure of the human ovary during a diagnostic ultrasound examination of 43 nonpregnant women is an order of magnitude less than the maximum values of ultrasonic quantities measured in vitro (Siddiqi et al. 1991) . Our current studies confirm this hypothesis to be also true in the case of routine "diagnostic" obstetric ultrasound examination of the human embryo and fetus wherein the (IL), is 8.5 2 2.2 dB and 11 3-6.0 dB for first-and second-trimester empty bladder conditions, respectively (see Table 1 ) . Additionally, despite the significant difference (p = 0.02) in gestational age between the EB and EB groups ( 12 + 4.1 weeks and 8.6 + 4.1 weeks, respectively-see Table  2 ), there was no statistically significant difference in the (IL), between EB and FB groups (p = 0.28), that is, 9.3 + 5.6 dB and 7.2 2 3.7 dB, respectively (see Table 2 ). We also estimated (Siddiqi et al. 1991 ) the fixed-path and overlying attenuation coefficients from the 43 nonpregnant women to be (A& = 3.0 t 1.7 dB/MHz and (A,,), = 0.72 + 0.62 dB/cm-MHz. These estimates compare favorably with those estimated in this study ((A,,) , = 3.6 5 2.2 dB/MHz and (A,,), = 0.82 + 0.54 dB/cm-MHz).
In our current study, (IL), for both the EB and FB groups individually or combined was independent of GA, daM wall, d,,, and d,,,, (see eqns 1 1 -14) . We previously estimated (Siddiqi et al. 1992 ) the in situ attenuation coefficients of both the anterior abdominal wall (AaM wa,, = 1.4 dB/cm-MHz) and the uterus (A,,,,, = 0.14 dB/cm-MHz) from in vivo exposimetry measurements from 23 nonpregnant women (nulliparas = 14, multiparas = 9) under both full bladder and empty bladder conditions. These results suggested that the abdominal wall is the principal source of ultrasonic energy loss in a reproductive, transabdominal ultrasound examination where multiple regression analysis provided the best fit (p = 0.056), i.e., ZLaMwall = 2.8 (dabdwal,)".w. Based on these data and the assumption that the thickness of the anterior abdominal wall does not change significantly during the first 20 weeks of gestation (see Tables 1 and 2 ), the (IL) would be expected to be independent of GA and dtoti for either the EB or FB groups individually or when combined (see eqns 11 and 15). The absence of any significant correlation between (IL) and dabdwall and do, is more difficult to explain. We suggest that beginning in the second trimester and extending into the early third trimester, there are changes in body fat and water content during normal human pregnancy (Pipe et al. 1979) . The greatest gain in fat is over the abdomen where the skin thickness increases by about 40% ( Hytten 1980) . Similarly, for women without clinically evident edema, the extracellular water content expands by approximately 1 to 2 L (Hytten et al. 1966) . These physiologic changes may partially explain the absence of any significant correlation between (IL) and daM wall and d,,, . All distance measurements from the sonogram image were made from an imaging system that assumes a propagation speed of 1540 m/s which could pose an error in actual distances for which the propagation speed is different from that of 1540 m/s. However, this does not create an uncertainty in the distance measurements or, for that matter, in the calculation of the various attenuation coefficients. A worst case uncertainty of tissue propagation speeds of 1540 2 40 m/s (a -+2.6% uncertainty) yields a 22.6% uncertainty in the distance determination. This is much less than the standard deviations of distance (see Table I ) which range from 20% of the mean value.
Despite our above assertion, using our previously acquired data (Siddiqi et al. 1992 ) (A,, wall = 1.4 dB/ cm-MHz and A,,,,, = 0.14 dB/cm-MHz), we developed an insertion loss prediction equation based on the sum of the insertion losses from the anterior abdominal wall and uterus (assuming all fluid paths to be lossless):
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In Table 3 are shown the insertion loss estimated from the measurements reported herein ( (ZL)measured = (IL), from Table 2 ) and the predicted insertion loss ( ( ZL)predlcted) as well as the insertion loss error (IL,,,) , defined as LT,,,
Two-tailed unpaired t tests between EB and FB groups for ( ZL)mensured, (ZL)predicted and ZL,,,, were not considered significant (p = 0.28, p = 0.46 and p = 0.57, respectively) and therefore the two groups for each of these quantities were combined. The mean value of &, was independent of GA (p = 0.28) and dtotal (p = 0.48). While the mean value of IL,,, (see Table 3) for the combined groups was 0.39%, a two-tailed, paired c test between ( ZL),,,,a and (ZL)pr.adicted was not considered significant (p = 0.33).
When we attempted to predict (IL) from our earlier work, the IL,,, as listed in Table 3 did not appear too great considering the complexity of the entire measurement procedure and the physiologic changes known to occur in body fat and water content during normal pregnancy. We therefore believe that predicting the insertion loss from our earlier work appears quite reasonable and does not call into question either this or the earlier study. In fact, we are heartened to note that this approach to predicting the in utero intensity Fig. 4 ).
Should the most conservative approach be desired ( "maximum" exposure), then an (Afp)? value of 1. I dB /MHz (the minimum value for all cases considered ) could be applied (note that one standard deviation from the mean is 1.5 dB/MHz) which is a factor of 3.2 less than the mean value. This approach obviously assumes that our sample size is truly representative of the population exposed to ultrasound and the value 1 .l dB/ MHz is a true absolute minimum. The NRCP ( 1992 ) has recommended the use of thefired-path attenuation coefficient values of 1.0 and 0.75 dB/MHz for firstand second-trimester obstetrical applications, respectively. These values are based on a worst-case ( "maximum" exposure ) approach and are consistent with the results of our study since no value was less than 1.0 dB/MHz, but inconsistent because there is no evidence that A, varies with gestational age up to about 20 weeks.
Both Aho and A,, are however dependent on d,,,,, for the combined groups (see eqns 24c and 29c and
Figs. 5 and 6). The homogeneous attenuation coefficient ( (Aho)g) for the combined groups is 0.52 -C 0.33 dB/cm-MHz. One standard deviation from the mean is 0.19 dB/cm-MHz and the minimum value of Aho is 0.14 dB/cm-MHz (in the FB group). For all applications of diagnostic ultrasound, FDA's Center for Devices and Radiological Health uses for regulatory purposes a derating factor, based on the homogeneous tissue model, of 0.3 dB/cm-MHz (FDA 1985 (FDA , 1993 and the Output Display Standard (AIUM/NEMA 1992) has recommended this same value. The mean and one standard deviation values of the results reported herein compare favorably with this value of 0.3 dB/cm-MHz ( see Fig. 5 ) _ Applying the homogeneous tissue model for estimating the "maximum" exposure in terms of predicting the highest in utero intensity from these results would require use of the value 0.14 dB/cm-MHz which is a factor of 3.7 less than the mean value.
The overlying attenuation coefficient ((A,,) ,?) for the combined groups is 0.82 ? 0.62 dB/cm-MHz. One standard deviation from the mean is 0.10 dB/cm-MHz and the minimum value of A, is 0.19 dB/cm-MHz In situ human obstetrical ultrasound exposimetry 0 T. A. SIDDIQI ef al. 391 (in the FB group). Thus, applying the overlying tissue model, the "maximum' ' exposure in terms of predicting the highest in utero intensity from these results is, therefore, 0.19 dB/cm-MHz which is a factor of 4.3 less than the mean value.
In summary, any one of the three tissue models may be used to estimate in utero acoustic quantities during the first and second trimesters of human pregnancy based on this study. All three tissue models yield a mean value of about a factor of 3 to 4 greater than their respective minimum values. We have provided the lowest values for these attenuation coefficients from our in vivo studies so that "maximum" exposure intensity estimates are also feasible for any given exposure condition. In the case of the overlying and homogeneous tissue models, there was a statistically significant correlation between their calculated attenuation coefficients and d,,,,, for the combined data set whereas there was no such dependency for the calculated$xed-path tissue model. We speculate that as we collect more data, either the homogeneous or the overlying tissue models will prove to be the best model for estimating in utero ultrasound intensity during routine obstetrical sonography.
